TULIO ORTEGA: Open Payments
NPI 1114013364 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$79,757 in 162 payments from 12 companies in 2025. Trend: 2023 $68,467 · 2024 $58,663 · 2025 $79,757
Speaker / faculty: $55,435Consulting: $15,855Travel & lodging: $4,243Food & beverage: $4,224
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 42 | $28,664 |
| E.R. Squibb & Sons, L.L.C. | 38 | $26,506 |
| Vanda Pharmaceuticals Inc. | 16 | $16,018 |
| ABBVIE INC. | 15 | $7,492 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $533 |
| Teva Pharmaceuticals USA, Inc. | 14 | $296 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Lundbeck LLC | 2 | $59 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
Products named: LYBALVI, COBENFY, FANAPT, VRAYLAR, CAPLYTA, ARISTADA, UZEDY, Auvelity.
Industry payments across NY — which companies pay providers there.
